Pancreatic Cancer Patients With BRCA Mutations Could Have a New Drug on the Way
According to a story from Worldpharmanews, a PARP inhibitor drug that is commonly used to treat ovarian cancer for patients with BRCA gene mutations could also be effective against pancreatic…